Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
COVID-19
Pharma
Moderna disappoints in RSV debut, excels in COVID sales
Moderna's RSV shot fell way short of expectations in its market debut, following disappointing results from its rivals GSK and Pfizer.
Kevin Dunleavy
Nov 7, 2024 10:51am
AGC Bio embarks on turnaround strategy under new CEO
Nov 7, 2024 10:10am
Novavax coughs up $123.8M to settle UK COVID vaccine dispute
Nov 6, 2024 10:27am
BioNTech's COVID vaccine sales surpassed expectations in Q3
Nov 4, 2024 11:32am
Moderna mounts campaign to boost vaccine eligibility awareness
Oct 24, 2024 10:40am
GSK takes mRNA patent fight to Moderna
Oct 15, 2024 6:34pm
More News
Pfizer CEO Bourla to meet with activist investor Starboard: FT
Oct 9, 2024 11:49am
Dupixent takes pharma DTC top spot in September
Oct 7, 2024 10:00am
Gilead recalls one lot of COVID drug over particulate concerns
Sep 25, 2024 8:57am
Moderna blamed after kids sent $2,000 COVID vaccine trial offer
Sep 25, 2024 7:22am
See more stories